NO20051936L - Anvendelse av 4-pyridylmetyl-ftalazinderivater for fremstilling av et medikament for behandling av myelodysplastiske syndromer. - Google Patents

Anvendelse av 4-pyridylmetyl-ftalazinderivater for fremstilling av et medikament for behandling av myelodysplastiske syndromer.

Info

Publication number
NO20051936L
NO20051936L NO20051936A NO20051936A NO20051936L NO 20051936 L NO20051936 L NO 20051936L NO 20051936 A NO20051936 A NO 20051936A NO 20051936 A NO20051936 A NO 20051936A NO 20051936 L NO20051936 L NO 20051936L
Authority
NO
Norway
Prior art keywords
pyridylmethyl
medicament
manufacture
myelodysplastic syndromes
treatment
Prior art date
Application number
NO20051936A
Other languages
English (en)
Inventor
Margaret Han Dugan
Alan List
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20051936L publication Critical patent/NO20051936L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen angår en fremgangsmåte for å behandle myelodysplastiske syndromer omfattende administtering av en terapeutisk effektiv mengde av et 4-pyridylmetylftalazinderivat til et varmblodig dyr som har behov for dette.
NO20051936A 2002-09-24 2005-04-20 Anvendelse av 4-pyridylmetyl-ftalazinderivater for fremstilling av et medikament for behandling av myelodysplastiske syndromer. NO20051936L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41317602P 2002-09-24 2002-09-24
PCT/EP2003/010578 WO2004028542A1 (en) 2002-09-24 2003-09-23 Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes

Publications (1)

Publication Number Publication Date
NO20051936L true NO20051936L (no) 2005-06-23

Family

ID=32043216

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051936A NO20051936L (no) 2002-09-24 2005-04-20 Anvendelse av 4-pyridylmetyl-ftalazinderivater for fremstilling av et medikament for behandling av myelodysplastiske syndromer.

Country Status (22)

Country Link
US (1) US20060128716A1 (no)
EP (1) EP1545534B1 (no)
JP (1) JP2006502195A (no)
KR (1) KR20050074450A (no)
CN (1) CN100372535C (no)
AT (1) ATE359789T1 (no)
AU (1) AU2003299065B2 (no)
BR (1) BR0314647A (no)
CA (1) CA2499738A1 (no)
CR (1) CR7754A (no)
DE (1) DE60313344T2 (no)
EC (1) ECSP055700A (no)
ES (1) ES2285251T3 (no)
HR (1) HRP20050281A2 (no)
MX (1) MXPA05003161A (no)
NO (1) NO20051936L (no)
PL (1) PL374696A1 (no)
PT (1) PT1545534E (no)
RS (1) RS20050228A (no)
RU (1) RU2353364C2 (no)
WO (1) WO2004028542A1 (no)
ZA (1) ZA200502212B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1282218A (zh) * 1997-10-15 2001-01-31 波拉克斯生物药品 使用砷化合物治疗原发性及转移性肿瘤疾病的组合物及方法
CN101277939A (zh) 2005-09-09 2008-10-01 布里斯托尔-迈尔斯斯奎布公司 无环ikur抑制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132458B2 (en) * 1994-08-10 2006-11-07 Chemaphor Inc. Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
IL115156A (en) * 1994-09-06 2000-07-16 Univ Georgia Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines
RU2136308C1 (ru) * 1994-11-16 1999-09-10 Жемчугов Владислав Евгеньевич Стимулятор роста костно-мозговых клеток человека
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
JP4673977B2 (ja) * 1999-03-30 2011-04-20 ノバルティス アーゲー 炎症性疾患治療用フタラジン誘導体
AR025068A1 (es) * 1999-08-10 2002-11-06 Bayer Corp Pirazinas sustituidas y piridazinas fusionadas, composicion farmaceutica que las comprenden, uso de dichos compuestos para la manufactura de un medicamentocon actividad inhibidora de angiogenesis
JP2003515558A (ja) * 1999-12-06 2003-05-07 ロード アイランド ホスピタル， ア ライフスパン パートナー 腫瘍を治療するためのメチロール含有化合物の使用

Also Published As

Publication number Publication date
MXPA05003161A (es) 2005-09-12
PL374696A1 (en) 2005-10-31
CN100372535C (zh) 2008-03-05
RS20050228A (sr) 2007-08-03
ZA200502212B (en) 2006-02-22
JP2006502195A (ja) 2006-01-19
KR20050074450A (ko) 2005-07-18
BR0314647A (pt) 2005-08-02
ES2285251T3 (es) 2007-11-16
WO2004028542A1 (en) 2004-04-08
US20060128716A1 (en) 2006-06-15
AU2003299065B2 (en) 2006-10-26
DE60313344D1 (de) 2007-05-31
CR7754A (es) 2005-12-02
PT1545534E (pt) 2007-06-22
ECSP055700A (es) 2005-08-11
HRP20050281A2 (en) 2006-07-31
DE60313344T2 (de) 2008-01-03
CN1684684A (zh) 2005-10-19
CA2499738A1 (en) 2004-04-08
AU2003299065A1 (en) 2004-04-19
EP1545534B1 (en) 2007-04-18
RU2353364C2 (ru) 2009-04-27
EP1545534A1 (en) 2005-06-29
ATE359789T1 (de) 2007-05-15
RU2005112711A (ru) 2006-02-27

Similar Documents

Publication Publication Date Title
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20034549D0 (no) Behandling av type 2 diabetes med inhibitorer av dipeptidyl peptidase IV
NO20044054L (no) Administrering av midler for behandling av betennelse
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
CY1106283T1 (el) Κινολινυλ-πυρρολοπυραζολες
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
DE50310516D1 (de) Fredericamycin-derivate
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
EE200200565A (et) Vaskulaarse kahjustava toimega kombinatsioonravi
ECSP055844A (es) Nuevos compuestos triciclicos
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
NO20072060L (no) 2-acylaminotiazolderivater
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
ATE369136T1 (de) Therapeutische behandlung
SE0004101D0 (sv) New use
PL374696A1 (en) Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes
EA200500427A1 (ru) Способы лечения пациентов, страдающих синдромом усталых ног или связанными с ним заболеваниями
SE0004827D0 (sv) Therapeutic compounds
CY1106385T1 (el) Χρηση παραγωγων της εποθειλονης για τη θepαπεια του υπepπαραθυρεοειδισμου
ATE413187T1 (de) Pharmazeutische zusammensetzungen mit interferon- tau
NO20030021D0 (no) Heterosykliske forbindelser som er inhibitorer for enzymet DPP-IV
ATE540920T1 (de) Aminobenzocycloheptenderivate, verfahren zu deren herstellung und deren verwendung in der therapie
BR0316010A (pt) Combinação

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application